Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Jan 13:2019:3012509.
doi: 10.1155/2019/3012509. eCollection 2019.

Cardiovascular Manifestations of Inflammatory Bowel Disease: Pathogenesis, Diagnosis, and Preventive Strategies

Affiliations
Review

Cardiovascular Manifestations of Inflammatory Bowel Disease: Pathogenesis, Diagnosis, and Preventive Strategies

Diana-Maria Bunu et al. Gastroenterol Res Pract. .

Abstract

Inflammatory bowel disease (IBD) refers to a group of chronic inflammatory diseases that targets mainly the gastrointestinal tract. The clinical presentation of IBD includes both gastrointestinal manifestations and extraintestinal manifestations (EIM). The reported cardiovascular manifestations in IBD patients include pericarditis, myocarditis, venous and arterial thromboembolism, arrhythmias, atrioventricular block, heart failure, endocarditis, valvulopathies, and Takayasu arteritis. The aim of this article is to review the available literature about the possible pathogenic mechanisms and determine preventive measures capable of reducing the incidence and severity of the cardiovascular manifestations. In IBD patients, the incidence of cardiovascular manifestations is low, but higher than that in the general population. Therefore, clinicians should pay attention to any new modification that might indicate cardiovascular involvement in IBD patients, and they should consider chronic inflammatory diseases in patients with cardiac conditions without an evident cause. Considering the role of inflammation in the development of cardiovascular manifestations, the management should include prevention of flares and maintenance of remission for as long as possible. Preventive measures should also include active screening and strict control of the cardiovascular risk factors in all IBD patients.

PubMed Disclaimer

References

    1. Kilcoyne A., Kaplan J. L., Gee M. S. Inflammatory bowel disease imaging: current practice and future directions. World Journal of Gastroenterology. 2016;22(3):917–932. doi: 10.3748/wjg.v22.i3.917. - DOI - PMC - PubMed
    1. Aslan A. N., Sarı C., Özer Sarı S., et al. Association between aortic stiffness and left ventricular function in inflammatory bowel disease. Cardiology Journal. 2016;23(2):202–210. doi: 10.5603/CJ.a2016.0008. - DOI - PubMed
    1. de Souza H. S. P., Fiocchi C. Immunopathogenesis of IBD: current state of the art. Nature Reviews Gastroenterology & Hepatology. 2016;13(1):13–27. doi: 10.1038/nrgastro.2015.186. - DOI - PubMed
    1. Neurath M. F. Cytokines in inflammatory bowel disease. Nature Reviews Immunology. 2014;14(5):329–342. doi: 10.1038/nri3661. - DOI - PubMed
    1. Coskun M., Vermeire S., Nielsen O. H. Novel targeted therapies for inflammatory bowel disease. Trends in Pharmacological Sciences. 2017;38(2):127–142. doi: 10.1016/j.tips.2016.10.014. - DOI - PubMed

LinkOut - more resources